HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asbestos In Johnson's Baby Powder May Come From Test Labs, J&J Says

Executive Summary

No asbestos found in 15 tests from same bottle FDA previously tested and reported finding asbestos. But a contractor's testing processes demonstrated potential for false findings of asbestos.

You may also be interested in...



NGOs To J&J: End Johnson’s Baby Powder Globally, Or Is Your Black Lives Support A PR Stunt?

J&J’s targeted marketing of talcum powder products to women of color verges on “corporate brutality,” Black Women for Wellness and more than 200 allied organizations suggest in recent letters to J&J leadership. The firm affirmed its commitment to equality and racial justice in June, but BWW wants J&J to “walk the talk.”

J&J’s Baby Powder Announcement Renews NGO Calls For Industry, FDA To End Use Of Talc In Cosmetics

The Environmental Working Group and US PIRG suggest that beauty and personal-care firms should avoid using talc in loose powders, if not all cosmetic products, and that the US FDA should consider banning the ingredient due to the potential for asbestos contamination, among other concerns.

J&J To End Johnson’s Baby Powder Sales In North American Markets, But Maintains Safety Convictions

The iconic talc-based product will no longer be available for purchase in the US and Canada after supplies run out. Standing firm on the safety of Johnson’s Baby Powder, J&J attributes the move to declining demand due to changing consumer habits, misinformation “and a constant barrage of litigation advertising.”

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel